- Home
- usa rhode island
- Companies
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Water and Wastewater
- Environmental
- Manufacturing, Other
- Health and Safety
- Electronics and Computers
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Banking & Finance / Insurance / Legal
- Plastics & Resins
- Communications / Telecom / Datacom
- Food and Beverage
- Construction & Construction Materials
- Mining
- Automobile & Ground Transport
- Defense
- Commercial
- Logistics
- Metal
- Paint
- Waste and Recycling
- Air and Climate
- University / Academia / Research
Medical Industry Technology Serving In Usa Rhode Island
391 companies found
Technologybased inWayne, PENNSYLVANIA (USA)
Palvella Therapeutics was founded to serve individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. We focus on developing therapies that specifically target the root ...
QTORIN™ rapamycin 3.9% is a novel targeted topical therapy being studied for Microcystic Lymphatic Malformations (Micro LM). Palvella is enrolling a phase 2 clinical study for people with Micro ...
Technologybased inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
In its MedTech division, Securecell is proudly developing Seraccess®, an innovative technology that fully automates the high-frequency collection, processing, and analysis of blood using next generation microfluidics for the monitoring and ...
Technologybased inMonterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA in in February 2022 in response ...
Technologybased inTempe, ARIZONA (USA)
Align Technology is a global medical device company that is changing lives through better smiles. We reimagine and reinvent the way orthodontic and restorative treatment is presented and delivered to millions of people around the world. We believe a ...
iTero intraoral scanners are designed to deliver speed, reliability, intuitive operations, and outstanding visualization capabilities for general practitioners or orthodontists. iTero scans have been used in more than 8.4 million restorative crowns, ...
Technologybased inAuburndale, MASSACHUSETTS (USA)
Imagin Medical, a surgical imaging company, is focusing on bladder cancer, the sixth most prevalent cancer in the U.S. and the third most common cancer in men. It is the most expensive form of cancer to treat over the lifetime of a patient because ...
Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopy while maintaining the advantages of both. By combining innovative optic and light sensor technology with the same FDA-approved imaging ...
Technologybased inGroningen, NETHERLANDS
CC Diagnostics recognises the preventability of cervical cancer in women. Cervical cancer is a worldwide problem, but with regular and decent screening it is mostly preventable. With regular screening, the early precancerous changes in cervical ...
CC Diagnostics collaborates with the DNA methylation ResearchGroup at the UMCG (heade by Dr G. Bea A. Wisman, molecular biologist and external scientific advisor for CC Diagnostics, and by Prof dr. Ed Schuuring, clinical scientist in ...
Technologybased inKirkland, WASHINGTON (USA)
Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients ...
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the symptoms. The Carillon System is ...
Technologybased inLeicester, UNITED KINGDOM
Freedom Hygiene is a technology driven company whose mission is to seek out innovative solutions that enable manufacturers and processors to reduce bacterial contamination in their facilities, extend production runs and, where applicable, prolong ...
At Freedom Hygiene, we recognise that conventional chemical treatments have a vital role to play in the daily hygienic cleaning of food and drinks manufacturing plants, healthcare and other facilities. The selection of chemical formulations can ...
Technologybased inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
Technologybased inYehuda, ISRAEL
Momentis was founded in 2013 when co-founders Chief Executive Officer Dvir Cohen and Professor Nir Shvalb, PhD, began exploring a revolutionary idea to create a surgical robotic system with fingers. At the time, Mr. Cohen was an awarded officer in ...
Robot-assisted surgery is regarded as a must-have by doctors and patients everywhere, due to advances in precision and dexterity, superior control, device multifunctionality, ergonomics, and avoidance of hand tremor and fulcrum ...
Technologybased inBrisbane City, AUSTRALIA
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science. Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in ...
Reveal new biology in health and disease; Accurately measuring the microorganisms in the microbiome, and their genes, means novel microbial signatures can be investigated for their significance in human ...
Technologybased inPoway, CALIFORNIA (USA)
VetStem Biopharma has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use ...
Since 2003, VetStem has been providing treatments for animals: Over 17,000 treatments for 30 difference species. Last year, the constant requests and pressure from veterinary colleagues and pet owners convinced our team to spin out a human stem cell ...
Technologybased inAddington, NEW ZEALAND
Izon Science brings precision and reproducibility to the world of nanoparticle separation and analysis for biological research and nanomedicine development. The qEV isolation platform is the trusted method for isolating extracellular vesicles (EVs), ...
Technologybased inParis, FRANCE
With nearly 15 years of experience, Cap Actuel is constantly looking for relevant solutions and technologies to meet the specific expectations of professionals concerned with offering quality services adapted to the main issues of beauty, health and ...
Unique concept whose patent is based on the simultaneous emission of Electrostimulation and Ultrasound, Capsule has been designed to quickly treat the body in the context of loss of volume, creation of muscle fibers, elimination of unsightliness ...
Technologybased inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
Novel MOA: REL-1017 works as an NMDAR channel blocker with preferential activity at hyperactive GluN1-GluN2D channels. REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major ...
Technologybased inGolden Valley, MINNESOTA (USA)
Inspire Medical Systems, Inc. is a medical innovation company based in Minneapolis, MN, dedicated to elevating and redefining the standard of care for obstructive sleep apnea. At Inspire, we are 100% committed to our patients. We believe in building ...
Technologybased inSan Carlos, CALIFORNIA (USA)
Empirical Spine, Inc., founded in 2015, is a privately held company creating a new standard in spine surgery that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life. The company is ...
LimiFlex is intended to provide segmental stabilization following decompression for grade 1 lumbar degenerative spondylolisthesis with spinal stenosis. LimiFlex is implanted through a dorsal approach, typically through the same incision used for the ...
Technologybased inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Gaucher disease is the most common lysosomal storage disease and is caused by mutations in GBA, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme. These mutations result in the misfolding and subsequent dysfunction of GCase, which ...
Technologybased inChester, UNITED KINGDOM
Byotrol's first antimicrobial technology was invented over 20 years ago, and since then we have developed a number of biocidal technologies and antimicrobial test methods, which challenge traditional disinfectant products and methods of cleaning, to ...
Technologybased inPhiladelphia, PENNSYLVANIA (USA)
Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients. Glaucoma is the second leading cause of blindness in the world and currently has no cure. To date, Avisi ...
VisiPlate is a next-generation aqueous shunt that aims to treat glaucoma. VisiPlate is 20x thinner than a human hair. VisiPlate® is an investigational device not available for use or sale in the United States. This website previews our ...
